Research Article Summary
-
The article critically evaluates the linear no-threshold (LNT) dose–response model, long employed by regulatory bodies for cancer risk assessment, by subjecting it to a broad series of toxicological and biological “stress tests” designed to probe its assumptions and predictive capacity at low doses; these tests include historical, physical, chemical, and biologically based challenges that demonstrate fundamental limitations of LNT’s capacity to describe low-dose effects.
-
It reviews the historical foundations of the LNT model, tracing its origin in early radiation genetics and its adoption from studies on fruit-fly mutation by early geneticists, and highlights how those foundations were based on assumptions and interpretations that do not universally hold across diverse biological endpoints.
-
Across multiple levels of biological organization — from molecular to organismal — evidence reveals that many dose–response relationships exhibit non-linear features, including adaptive responses such as hormesis, thresholds, or repair mechanisms that contradict the strict proportionality implied by LNT when extrapolating from high-dose to low-dose exposures.
-
The article argues that toxicological data and experimental results from a wide range of studies have failed to support LNT’s predictions in low-dose regions for endpoints beyond those narrowly defined in its original formulation, suggesting that reliance on LNT leads to scientifically unjustified conclusions about risk and may misinform regulatory policy.
-
It concludes that because of these substantive scientific challenges — including inconsistencies with evolutionary, molecular, and organismal biology, and the existence of alternative dose–response models that better accommodate observed biological phenomena — continued policy use of LNT for low-dose risk assessment is not supported by current toxicological evidence and should be reconsidered in favor of models that reflect biological complexity.